Zobrazeno 1 - 10
of 36
pro vyhledávání: '"factor H-like protein 1"'
Autor:
Felix Poppelaars, Elena Goicoechea de Jorge, Ilse Jongerius, Antje J. Baeumner, Mark-Steven Steiner, Mihály Józsi, Erik J. M. Toonen, Diana Pauly, the SciFiMed consortium
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/4dbfd5f478dd4fdaaa760406d5a68fe0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Felix Poppelaars, Elena Goicoechea de Jorge, Ilse Jongerius, Antje J. Baeumner, Mark-Steven Steiner, Mihály Józsi, Erik J. M. Toonen, Diana Pauly, the SciFiMed consortium
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Inflammation is a common denominator of diseases. The complement system, an intrinsic part of the innate immune system, is a key driver of inflammation in numerous disorders. Recently, a family of proteins has been suggested to be of vital importance
Externí odkaz:
https://doaj.org/article/c90542082e2c49b8aa71b38eff1c9f84
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The alternative pathway regulator Factor H-like protein 1 (FHL-1) is composed of the first 7 N-terminal complement control protein domains of Factor H (FH) and protects host surfaces from uncontrolled complement attack. Although FHL-1 shares the N-te
Externí odkaz:
https://doaj.org/article/b32ca20a70e6450e9493985d6e27eacb
Publikováno v:
Frontiers in Immunology. 13
There is an error in the Funding statement as published. The correct name for the Funder is “the European Union’s Horizon 2020 research and innovation programme”. The correct Funding statement is “This project has received funding from the Eu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::13d6e1dc78625d19e6cad42db407d453
https://doi.org/10.3389/fimmu.2022.937609
https://doi.org/10.3389/fimmu.2022.937609
Autor:
Landsteiner Laboratory, AII - Inflammatory diseases
Publikováno v:
Frontiers in immunology, 13:937609. Frontiers Media S.A.
There is an error in the Funding statement as published. The correct name for the Funder is “the European Union’s Horizon 2020 research and innovation programme”. The correct Funding statement is “This project has received funding from the Eu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::4eb2d28291de58838d16f289c8ceedb8
https://pure.amc.nl/en/publications/corrigendum(735d2605-44ec-4e35-b262-1a1c1840b1dd).html
https://pure.amc.nl/en/publications/corrigendum(735d2605-44ec-4e35-b262-1a1c1840b1dd).html
Publikováno v:
Frontiers in Immunology. 12
Inflammation is a common denominator of diseases. The complement system, an intrinsic part of the innate immune system, is a key driver of inflammation in numerous disorders. Recently, a family of proteins has been suggested to be of vital importance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___01423::d417587559ac30b34b8621e4daecb029
https://doi.org/10.3389/fimmu.2021.660194
https://doi.org/10.3389/fimmu.2021.660194
Publikováno v:
Frontiers in immunology. 12
Inflammation is a common denominator of diseases. The complement system, an intrinsic part of the innate immune system, is a key driver of inflammation in numerous disorders. Recently, a family of proteins has been suggested to be of vital importance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::897a29631ec345380b048a7d34bf093b
http://www.scopus.com/inward/record.url?scp=85104207657&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85104207657&partnerID=8YFLogxK
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
The alternative pathway regulator Factor H-like protein 1 (FHL-1) is composed of the first 7 N-terminal complement control protein domains of Factor H (FH) and protects host surfaces from uncontrolled complement attack. Although FHL-1 shares the N-te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c1aa9cc3b02d293bb71dc6fa42874e97
https://www.frontiersin.org/article/10.3389/fimmu.2020.596415/full
https://www.frontiersin.org/article/10.3389/fimmu.2020.596415/full
Autor:
Pujol-Lereis, Luciana M., Liebisch, Gerhard, Schick, Tina, Lin, Yuchen, Grassmann, Felix, Uchida, Koji, Zipfel, Peter F., Fauser, Sascha, Skerka, Christine, Weber, Bernhard H. F.
Publikováno v:
PLoS ONE
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
PLoS ONE, Vol 13, Iss 8, p e0200739 (2018)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
PLoS ONE, Vol 13, Iss 8, p e0200739 (2018)
Sphingolipids are bioactive molecules associated with oxidative stress, inflammation, and neurodegenerative diseases, but poorly studied in the context of age-related macular degeneration (AMD), a prevalent sight-threatening disease of the ageing ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f1e2a1219788a956626884e6908d6b2